Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darell D Bigner

Showing results (41-50 of 242) with videos related to

Pageof 25
Sort By:
Nuclear Medicine and Biology|August 4, 2009
Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumabAbraham Boskovitz, Roger E McLendon, Tatsunori Okamura, et al.
Neuro-Oncology|July 29, 2004
Poliovirus receptor CD155-targeted oncolysis of gliomaMelinda K Merrill, Guenter Bernhardt, John H Sampson, et al.
Nature Chemical Biology|September 25, 2012
Enzyme redesign guided by cancer-derived IDH1 mutationsZachary J Reitman, Bryan D Choi, Ivan Spasojevic, et al.
Hybridoma (2005)|December 23, 2009
Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastomaChien-Tsun Kuan, Carol J Wikstrand, Roger E McLendon, et al.
Expert Opinion on Biological Therapy|September 1, 2004
Monoclonal antibodies for brain tumour treatmentAbraham Boskovitz, Carol J Wikstrand, Chien-Tsun Kuan, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 14, 2024
Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3Inés Fallon, Henar Hernando, Olga Almacellas-Rabaiget, et al.
Expert Opinion on Biological Therapy|April 1, 2011
Bispecific antibodies engage T cells for antitumor immunotherapyBryan D Choi, Mingqing Cai, Darell D Bigner, et al.
International Journal of Cancer|November 26, 2009
Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomasChien-Tsun Kuan, Nidhi Srivastava, Roger E McLendon, et al.
Expert Review of Clinical Pharmacology|August 10, 2013
An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastomaPatrick C Gedeon, Bryan D Choi, Tiffany R Hodges, et al.
Biological Chemistry|December 2, 2008
Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosisYingmiao Liu, Chien-Tsun Kuan, Jing Mi, et al.
Pageof 25

Showing results (41-50 of 242) with videos related to

Sort By:
Pageof 25
Nuclear Medicine and Biology|August 4, 2009
Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumabAbraham Boskovitz, Roger E McLendon, Tatsunori Okamura, et al.
Neuro-Oncology|July 29, 2004
Poliovirus receptor CD155-targeted oncolysis of gliomaMelinda K Merrill, Guenter Bernhardt, John H Sampson, et al.
Nature Chemical Biology|September 25, 2012
Enzyme redesign guided by cancer-derived IDH1 mutationsZachary J Reitman, Bryan D Choi, Ivan Spasojevic, et al.
Hybridoma (2005)|December 23, 2009
Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastomaChien-Tsun Kuan, Carol J Wikstrand, Roger E McLendon, et al.
Expert Opinion on Biological Therapy|September 1, 2004
Monoclonal antibodies for brain tumour treatmentAbraham Boskovitz, Carol J Wikstrand, Chien-Tsun Kuan, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 14, 2024
Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3Inés Fallon, Henar Hernando, Olga Almacellas-Rabaiget, et al.
Expert Opinion on Biological Therapy|April 1, 2011
Bispecific antibodies engage T cells for antitumor immunotherapyBryan D Choi, Mingqing Cai, Darell D Bigner, et al.
International Journal of Cancer|November 26, 2009
Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomasChien-Tsun Kuan, Nidhi Srivastava, Roger E McLendon, et al.
Expert Review of Clinical Pharmacology|August 10, 2013
An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastomaPatrick C Gedeon, Bryan D Choi, Tiffany R Hodges, et al.
Biological Chemistry|December 2, 2008
Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosisYingmiao Liu, Chien-Tsun Kuan, Jing Mi, et al.
Pageof 25